INS and obesity due to melanocortin 4 receptor deficiency: Although luteolin was weakly correlated with DR in previous research, it manifests a positive impact on metabolic disorders like diabetes and obesity by modulating glucose metabolism and insulin sensitivity (Queiroz et al., 2021; Ge et al., 2022).